Bishal Gyawali, Associate Professor at Queen’s University, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“New open access paper from BG Lab alert!
In this new paper led by my colleague Ramila Shilpakar and my trainee Brian Shkabari, we find that some cancer drugs’ prices in Nepal can vary by up to almost 1000% based on which hospital you go to or which brand you choose!
Many drug’s are unavailable and when available, they are unaffordable. The ground reality of global oncology.”
Title: Availability, Affordability, and Variations in Price of GI Cancer Medicines in Nepal
Authors: Mohamed E. Salem, Alberto Puccini, Elizabeth Mauer, Thierry André, Thomas J. George, Josep Tabernero, Frank A. Sinicrope, Jeanne Tie, Scott Kopetz, Eric Van Cutsem, Sara Lonardi, Michael J. Overman, David Foureau
Read the Full Article on JCO Global Oncology
More posts featuring Bishal Gyawali.
